innoscripta Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Michael Hohenester

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	13.3yrs
CEO ownership	n/a
Management average tenure	7.3yrs
Board average tenure	less than a year

Recent management updates

No updates

Recent updates

No updates

CEO

Michael Hohenester (41 yo)

13.3yrs

Tenure

Mr. Michael Georg Hohenester is Co-Chief Executive Officer of Innoscripta AG from December 2022 and its Member of the Management Board since 2012. Prior to this position, Michael founded Curefab GmbH in Mu...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Michael Hohenester	CEO & Member of the Management Board	13.3yrs	no data	no data
Alexander Meyer	Co-CEO, CFO & Member of the Management Board	7.3yrs	no data	no data
Sebastian Schwertlein	COO & Member of the Management Board	less than a year	no data	no data

7.3yrs

Average Tenure

38yo

Average Age

Experienced Management: 1INN's management team is seasoned and experienced (7.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Philipp von Ilberg	Chairman of the Supervisory Board	less than a year	no data	no data
Erik Massmann	Member of the Supervisory Board	less than a year	no data	no data
Stefan Bülow	Member of the Supervisory Board	less than a year	no data	no data
Kai Andrejewski	Member of the Supervisory Board	less than a year	no data	no data
Duygu Uysal	Member of the Supervisory Board	less than a year	no data	no data
Christoph Möller	Deputy Chairman of the Supervisory Board	1.9yrs	no data	no data

0.6yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 1INN's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/24 15:56
End of Day Share Price	2025/05/23 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

innoscripta SE is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.